CN101426903A - 基于细胞核形态鉴定并靶向肿瘤干细胞的方法 - Google Patents

基于细胞核形态鉴定并靶向肿瘤干细胞的方法 Download PDF

Info

Publication number
CN101426903A
CN101426903A CNA2006800525889A CN200680052588A CN101426903A CN 101426903 A CN101426903 A CN 101426903A CN A2006800525889 A CNA2006800525889 A CN A2006800525889A CN 200680052588 A CN200680052588 A CN 200680052588A CN 101426903 A CN101426903 A CN 101426903A
Authority
CN
China
Prior art keywords
bell
nuclei
shaped
cells
nuclear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800525889A
Other languages
English (en)
Chinese (zh)
Inventor
W·G·蒂利
E·V·戈斯特杰瓦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of CN101426903A publication Critical patent/CN101426903A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0695—Stem cells; Progenitor cells; Precursor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2006800525889A 2005-12-09 2006-12-08 基于细胞核形态鉴定并靶向肿瘤干细胞的方法 Pending CN101426903A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74895105P 2005-12-09 2005-12-09
US60/748,951 2005-12-09

Publications (1)

Publication Number Publication Date
CN101426903A true CN101426903A (zh) 2009-05-06

Family

ID=38099345

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800525889A Pending CN101426903A (zh) 2005-12-09 2006-12-08 基于细胞核形态鉴定并靶向肿瘤干细胞的方法

Country Status (12)

Country Link
US (1) US20090304662A1 (enExample)
EP (1) EP1963490A2 (enExample)
JP (1) JP2009518438A (enExample)
KR (1) KR20080079302A (enExample)
CN (1) CN101426903A (enExample)
AU (1) AU2006321710A1 (enExample)
BR (1) BRPI0619599A2 (enExample)
CA (1) CA2632754A1 (enExample)
IL (1) IL191746A0 (enExample)
RU (1) RU2008127844A (enExample)
WO (1) WO2007067795A2 (enExample)
ZA (1) ZA200804973B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103890582A (zh) * 2011-06-02 2014-06-25 麻省理工学院 后核干细胞的dsRNA/DNA杂合基因组复制中间体
WO2020224311A1 (zh) * 2019-05-09 2020-11-12 量准(武汉)生命科技有限公司 一种人类唾液中c型反应性蛋白彩色成像的方法及装置

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007101496A (ru) 2004-06-17 2008-07-27 Массачусетс Инститьют Оф Текнолоджи (Us) Способы идентификации стволовых клеток, основанные на ядерных морфотипах
CA2692072A1 (en) * 2007-06-13 2008-12-24 Massachusetts Institute Of Technology Methods and agents for inhibiting tumor growth
IT1392908B1 (it) 2008-09-29 2012-04-02 Italfarmaco Spa Uso degli inibitori delle istone-deacetilasi per la cura di sindromi mieloproliferative philadelphia-negative
US8217079B2 (en) 2010-03-26 2012-07-10 Italfarmaco Spa Method for treating Philadelphia-negative myeloproliferative syndromes
CA2815787A1 (en) 2010-10-25 2012-05-10 Massachusetts Institute Of Technology Wound healing metakaryotic stem cells and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361336B1 (en) * 1997-09-18 2008-04-22 Ivan Bergstein Methods of cancer therapy targeted against a cancer stem line
US6984522B2 (en) * 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
RU2007101496A (ru) * 2004-06-17 2008-07-27 Массачусетс Инститьют Оф Текнолоджи (Us) Способы идентификации стволовых клеток, основанные на ядерных морфотипах

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103890582A (zh) * 2011-06-02 2014-06-25 麻省理工学院 后核干细胞的dsRNA/DNA杂合基因组复制中间体
WO2020224311A1 (zh) * 2019-05-09 2020-11-12 量准(武汉)生命科技有限公司 一种人类唾液中c型反应性蛋白彩色成像的方法及装置

Also Published As

Publication number Publication date
WO2007067795A3 (en) 2007-08-23
AU2006321710A1 (en) 2007-06-14
WO2007067795A2 (en) 2007-06-14
RU2008127844A (ru) 2010-02-10
IL191746A0 (en) 2008-12-29
KR20080079302A (ko) 2008-08-29
ZA200804973B (en) 2009-11-25
JP2009518438A (ja) 2009-05-07
CA2632754A1 (en) 2007-06-14
EP1963490A2 (en) 2008-09-03
US20090304662A1 (en) 2009-12-10
BRPI0619599A2 (pt) 2011-10-11

Similar Documents

Publication Publication Date Title
US8465943B2 (en) Methods for identifying stem cells based on nuclear morphotypes
CN102216777B (zh) 通过检测细胞和合胞体的荧光来鉴别干细胞的方法
JP5171945B2 (ja) 腫瘍増殖を阻害する方法および薬剤
EP3006941A1 (en) Method for screening cancer metastasis inhibitor using culture of cells or spheroidically aggregated cells in which lysyl-trna synthetase is regulated to be expressed or unexpressed
WO2008115517A2 (en) Methods for identifying stem cells by detecting autofluorescence of cells and syncytia
CN101426903A (zh) 基于细胞核形态鉴定并靶向肿瘤干细胞的方法
Sun et al. Inhibition of nucleostemin upregulates CDX2 expression in HT29 cells in response to bile acid exposure: implications in the pathogenesis of Barrett’s esophagus
Fleszar Follicular fluid, ovarian cortical inclusion cysts, and substrate curvature increase the cancerous progression of fallopian tube epithelial cells
WO2025245229A1 (en) Regulating mucus production
Joseph et al. Paired colonic epithelial cell lines derived from tumor and normal sites of the same individual's intestine as tools to study the pathophysiology of colon cancer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090506